vitiligo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Confirmed diagnosis of stable-stage vitiligo?; Aged 18-65 years regardless of gender? (18-65);?Voluntarily enrolled with signed informed consent?.
Exclusion criteria
Exclusion criteria: Individuals with severe mental illness or cognitive impairment lacking capacity to act are unsuitable for clinical research participation; other cases deemed ineligible by investigators; patients who have undergone treatment within the past three months with liver and kidney function failing to meet laboratory parameters.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cell Viability Assay;Determination of Melanin Content;Determination of Tyrosinase Activity;Fluorescent Polymerase Chain Reaction;Western blot;Immunohistochemical detection of SCF, c-kit gene, and protein expression.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Interleukin 1, 1ß, 2, 4, 5, 6, 8, 10, 12, 12p, 18;TNF-a;SCF;c-kit; | — |
Countries
Chinese
Contacts
Capital Medical University Affiliated Beijing Hospital of Traditional Chinese Medicine